I was diagnosed with CML in November of 2013. I have been on my current reduced dose of 300 mgs of Tasigna since August 2014 (9 months). Yesterday I received my Brca Int Scale % result of 0.0950. The lowest I have ever been achieving MMR Major Molecular Response. My Hematologist Oncologist wants to increase my dose by another pill a day in an attempt for me to reach CCyR or 0%. Would you do it? I wanted to stay on the dose I am on and see if I can reach 0% but he seems to think I have plateaued with a 0.27% in December 2014 and 0.3% three months ago. He also believes reaching 0% sooner would be better in the long run. I really want the CCyR but I am dreading the possible increase in the side affects. My PLTs and HGB dropped so low previously I required multiple transfusions not to mention the tiredness and headaches. Am I being a baby? Should I take this head on? Any input is greatly appreciated. Thanks, Diane.

#1
Posted 19 May 2015 - 01:32 PM
11/29/2013 Diagnosis PLT 538 K/uL HGB 6.2 G/DL, HCT 18.5% WBC 557.00 K/uL Enlarged Spleen
Sprycel 100 MG
Hydroxyurea initially 4 capsules daily
By 4/2014 PLT 27, WBC and RBC Low. Off Sprycel for 3 weeks
After 3 weeks, blood counts normal, no mutation, back on Sprycel 50 MG
5/2014 PLT too Low off Sprycel 4 weeks
6/2014 started Tasigna
Side Effects- Nauseous, Headaches, Tired
8/2014 second opinion Mass General CML Specialist
Continuous transfusions of RBC, PLTs and NEualasta to temp increase blood cells to fight off infection.
Remain on full dose Tasigna
Major p210 International Scale
05/11/2015 0.0950
09/08/2015 0.0782
01/19/2016 0.0310
04/28/2016 0.0161
07/25/2016 0.0244
11/04/2016 0.0140
02/06/2017 0.0129
05/23/2017 0.0087
Today 0.0000
Be well, Diane.
#2
Posted 19 May 2015 - 02:28 PM
What is the risk of progression if you stay at the lower dose and maybe never reach 0% ? If it were me, I would stay at the lower dose and have manageable side effects as long as it was safe and it keeps the leukemia stable.
#3
Posted 19 May 2015 - 03:15 PM
I assume you started at the full dosage of tasignia at diagnosis. Did you move to the reduced dosage because of side-effects? Were they much worse than what you have now? Is it intolerable to go back to the previous state? Because getting to CCyR seems to be pretty important.
Diagnosed in February 2014. Started Imatinib 400 in April.
2014: 3.18 0.91
2015: 0.22 0.16 0.04 0.55
2016: 0.71 0.66
(Started Imatinib 600 in April 2016)
2016: 0.42 0.13 0.45
2017: 0.17 0.06 0.10 0.06 0.34
#4
Posted 19 May 2015 - 04:20 PM
FISH 92%
BMB 9:22 translocation
1/19/15 began 400 mg gleevec
1/22/15 bcr 37.2 IS
2/6/15 bcr 12.5 IS
3/26/15 bcr 10.3 IS
6/29/15 bcr 7.5 IS
9/24/15 bcr 0.8 IS
1/4/16 bcr 0.3 IS
Started 100 mg dasatinib, mutation analysis negative
4/20/16 bcr 0.03 IS
8/8/16 bcr 0.007 IS
12/6/16 bcr 0.002 IS
Lowered dasatinib to 70 mg
4/10/17 bcr 0.001 IS
Lowered dasatinib to 50 mg
7/5/17 bcr 0.004 IS
8/10/17 bcr 0.001. Stopped TKI in prep for September surgery.
9/10/17 bcr 0.006
10/10/17 bcr 0.088
#5
Posted 19 May 2015 - 04:37 PM
CCyR (-2 log) is less than MMR (-3 log) so of course you meant CMR (PCRU). You are in a very good place right now with the MMR so no change is necessary, although if you wish you could try 400mg twice daily, which might not increase your side effects if taken as a split dosage of 200mg twice daily instead of your current 300mg once daily. Then if needed you could revert to 300mg once daily. It is really just a personal choice.
There is probably nothing to be gained by forcing a faster response at the expense of returning to severe side effects. The issue with fast response is not so much forcing one, but rather that your CML can respond easily to TKI therapy. This is a difference most Oncs do not understand, which is that a fast response on high dosage does not assure better long term results, but rather it is the ability to easily control the CML as usually shown by a fast response to TKI drugs which is more significant. Hopefully that makes sense since it is a little hard to explain.
#6
Posted 19 May 2015 - 08:18 PM
Thanks Trey, I was confused as I thought Complete Cytogenetic Response (CCyR) was No PH+ cells detected and what the goal was as opposed to CMR Complete Molecular Response. Sorry if I'm confusing people. Thanks again.
11/29/2013 Diagnosis PLT 538 K/uL HGB 6.2 G/DL, HCT 18.5% WBC 557.00 K/uL Enlarged Spleen
Sprycel 100 MG
Hydroxyurea initially 4 capsules daily
By 4/2014 PLT 27, WBC and RBC Low. Off Sprycel for 3 weeks
After 3 weeks, blood counts normal, no mutation, back on Sprycel 50 MG
5/2014 PLT too Low off Sprycel 4 weeks
6/2014 started Tasigna
Side Effects- Nauseous, Headaches, Tired
8/2014 second opinion Mass General CML Specialist
Continuous transfusions of RBC, PLTs and NEualasta to temp increase blood cells to fight off infection.
Remain on full dose Tasigna
Major p210 International Scale
05/11/2015 0.0950
09/08/2015 0.0782
01/19/2016 0.0310
04/28/2016 0.0161
07/25/2016 0.0244
11/04/2016 0.0140
02/06/2017 0.0129
05/23/2017 0.0087
Today 0.0000
Be well, Diane.
Also tagged with one or more of these keywords: Tasigna, Increased Dose
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users